Generation of Beta Cells from Stem Cells—State of the Art
Saturday, June 26, at 1:45 p.m. ET
Q&A with Jeffrey R. Millman, PhD
[gap height=”40″]
What is your presentation about?
This presentation will describe the progress that has been made recently in the generation of insulin-secreting islets from human pluripotent stem cells. Control of both soluble and insoluble cues has enabled improved generation of islets across multiple stem cell lines. These cells have utility as a self-renewal source for diabetes cell replacement therapy and modeling disease in the dish.
What makes this topic important in 2021?
Cellular therapy for diabetes using lab-grown islets from stem cells has the potential to revolutionize how the field manages diabetes for many patients. This is a fast moving field, with significant progress made every year.
Which subset of attendees shouldn’t miss this presentation?
Those interested in cellular therapy, stem cells, and organoids shouldn’t miss this presentation.
VIEW THIS PRESENTATION
Already registered?
View this presentation at ADA2021.org
Not yet registered?
Register now to access all presentations from the Virtual 81st Scientific Sessions